Katalog der Deutschen Nationalbibliothek

Go to:

Knowledge Web

Person
Person

Person

Carsten Buhmann (1965-)

Arzt

Name

Carsten Buhmann

Time

1965- (Date of birth and death)

Place

Deutschland

Gender

männlich

Academic degree

PD Dr. med.

Profession

Arzt (characteristic profession)
Neurologe
Privatdozent

Variant

C. Buhmann

Related

Universitätsklinikum Hamburg-Eppendorf

Further information

Univ. Hamburg, Medizinische Fak., Universitätsklinikum Hamburg-Eppendorf, Kopf- und Neurozentrum, Klinik und Poliklinik für Neurologie, Leiter Ambulanzzentrum – Bereich Neurologie

Record type

Person

GND-Identifier

114699682

Record ID

114699682

Involved in

show all

Added value of FDG-PET for detection of progressive supranuclear palsy

Parkinson´s day-clinic: which patients should be selected and what services should be offered for successful therapy?

Diagnosis and treatment of autonomic failure, pain and sleep disturbances in Parkinson’s disease: guideline “Parkinson’s disease” of the German Society of Neurology

Added value of FDG-PET for detection of progressive supranuclear palsy

Automatic covariance pattern analysis outperforms visual reading of 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) in variant progressive supranuclear palsy

Brain MRI in Progressive Supranuclear Palsy with Richardson's Syndrome and Variant Phenotypes

Effect of subthalamic and nigral deep brain stimulation on speech and voice in Parkinson’s patients

Clinicians’ viewpoints on current paradigms of care and research in Parkinson’s disease

German Society of Neurology guidelines for the diagnosis and treatment of cognitive impairment and affective disorders in people with Parkinson’s disease: new spotlights on diagnostic procedures and non-pharmacological interventions

Tips and tricks in tremor treatment

Guideline “Parkinson’s disease” of the German Society of Neurology (Deutsche Gesellschaft für Neurologie): concepts of care

Fahrtauglichkeit bei Parkinson-Erkrankung

Added value of FDG-PET for detection of progressive supranuclear palsy

Diagnosis and treatment of Parkinson´s disease (guideline of the German Society for Neurology)

Diagnostics and treatment of impulse control disorders, psychosis and delirium: systemic review-based recommendations - guideline "Parkinson’s disease" of the German Society of Neurology

Diagnostics and treatment of impulse control disorders, psychosis and delirium: systemic review-based recommendations - guideline “Parkinson’s disease” of the German Society of Neurology

Guideline "Parkinson's disease" of the German Society of Neurology (Deutsche Gesellschaft für Neurologie) : concepts of care

Guideline “Parkinson’s disease” of the German Society of Neurology (Deutsche Gesellschaft für Neurologie): concepts of care

Pharmacotherapy of motor symptoms in early and mid-stage Parkinson’s disease: guideline “Parkinson’s disease” of the German Society of Neurology

Tips and tricks in tremor treatment

Therapeutic use of medical Cannabis in neurological diseases: a clinical update

Correction to: Role of dopamine agonists in Parkinson's disease therapy

Role of dopamine agonists in Parkinson's disease therapy

Blood neurofilament light chain in Parkinson’s disease

Cannabinoide in der Neurologie

Automatic covariance pattern analysis outperforms visual reading of 18 F‐fluorodeoxyglucose‐positron emission tomography (FDG‐PET) in variant progressive supranuclear palsy

Automatic covariance pattern analysis outperforms visual reading of 18 F‐fluorodeoxyglucose‐positron emission tomography (FDG‐PET) in variant progressive supranuclear palsy

Beeinträchtigen Impulskontrollstörungen die Fahrleistung bei Parkinson-Patienten?

Botulinum neurotoxin type A in the interdisciplinary treatment of sialorrhea in adults and children : update and practice recommendations

Blood-based biomarker in Parkinson’s disease: potential for future applications in clinical research and practice

Serum neurofilament light chain and postural instability/gait difficulty (PIGD) subtypes of Parkinson’s disease in the MARK-PD study

Stellenwert der COMT-Hemmer in der Therapie motorischer Fluktuationen

Erratum: Behandlung der Sialorrhoe mit Botulinum Neurotoxin Typ A – Konsentierte Praxisempfehlungen für Kinder und Erwachsene

Behandlung der Sialorrhoe mit Botulinum Neurotoxin Typ A – Konsentierte Praxisempfehlungen für Kinder und Erwachsene

(18F) FDG-PET zur Differenzialdiagnostik und Prognostik der neurodegenerativen Parkinson-Syndrome: Update 2022

Blood-based biomarker in Parkinson’s disease : potential for future applications in clinical research and practice

Blood-based biomarker in Parkinson’s disease: potential for future applications in clinical research and practice

Fahrtauglichkeit bei Parkinson-Erkrankung

Dysphagia screening in Parkinson's Disease : a diagnostic accuracy cross-sectional study investigating the applicability of the Gugging Swallowing Screen (GUSS)

Parkinson : Fallbeispiele aus der Klinik

Parkinson : Fallbeispiele aus der Klinik

The ability of the eating assessment tool-10 to detect penetration and aspiration in Parkinson’s disease

Dopamine boosts intention and action awareness in Parkinson’s disease

Pallidal lead placement in dystonia: leads of non-responders are contained within an anatomical range defined by responders

Die Hamburger Parkinson-Tagesklinik: Ein neues Behandlungskonzept an der Grenze zwischen stationärer und ambulanter Versorgung

Empfehlung zum differenzierten Einsatz nuklearmedizinischer Diagnostik bei Parkinson-Syndromen

Recommendations for Standards of Network Care for Patients with Parkinson’s Disease in Germany

Sex disparities in the self-evaluation of subthalamic deep brain stimulation effects on mood and personality in Parkinson's disease patients

Specialized Staff for the Care of People with Parkinson’s Disease in Germany: An Overview

Conditioned pain modulation in drug-naïve patients with de novo Parkinson’s disease

Evidence for the use of cannabinoids in Parkinson’s disease

Dyskinesia in multiple system atrophy and progressive supranuclear palsy

The Hamburg Parkinson day-clinic: a new treatment concept at the border of in- and outpatient care

Das idiopathische Parkinsonsyndrom und Schmerz – diagnostische und therapeutische Ansätze für ein herausforderndes nicht-motorisches Symptom

Cannabis bei Parkinson – Hype oder Heilmittel?

Critical Dysphagia is Common in Parkinson Disease and Occurs Even in Early Stages: A Prospective Cohort Study

Pain in Parkinson disease: a cross-sectional survey of its prevalence, specifics, and therapy

Levodopa/carbidopa intestinal gel (LCIG) infusion as mono- or combination therapy

The impact of Parkinson disease on patients’ sexuality and relationship

Interkulturelle Adaption der AIMS in deutscher Sprache : Eine Skala für abnorme unwillkürliche Bewegungen
Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

DNB portal